$RZRA
SEC EDGAR Filings Hub
2 Filings
$RZRA · Rezera Inc. SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for Rezera Inc. ($RZRA) from November 5, 2026 through November 9, 2026, including 0 Form 10-K annual reports, 0 Form 10-Q quarterly earnings reports, 0 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
Check $RZRA portfolio concentration →
View $RZRA Congress trades →
Research $RZRA stock →
All SEC filings →
Total Filings2
10-K / 10-Q Reports0
8-K Material Events0
Form 4 Insider0
High-Impact0
Latest FilingNovember 9, 2026
Browse SEC Filings by Form Type
Latest $RZRA SEC Filings & AI Summaries (2)
November 9, 2026
$RZRA S-1 — Rezera Inc.
A clinical-stage NLRP3 biotech with a GSK strategic interest is moving toward a Nasdaq IPO ahead of a pivotal Phase 3 PAD trial.
November 5, 2026
$RZRA S-1 — Rezera Inc.
A clinical-stage biotech with a GSK-anchored ~10% indication of interest is bringing a novel oral NLRP3 inhibitor to public markets ahead of a pivotal Phase 3 trial.
Related & Peer Company SEC Filing Hubs